WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

The Tracker / February 2026 / K260149

510(k) cleared

Versus Catheter (VS110-9NB)

Liquet Medical, Inc. · Feb 17, 2026 · K260149

FDA cleared the Versus Catheter (VS110-9NB) from Liquet Medical, Inc. on Feb 17, 2026 under K260149, a special 510(k). The device falls under product code QEY, Mechanical Thrombolysis Catheter, regulated at 21 CFR 870.5150 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on Jan 20, 2026. The decision came 28 days later, inside the 90 FDA-day goal for a 510(k).

This is the only decision on file for Liquet Medical, Inc. in the last 12 months of the tracker.

Questions & Answers

What did FDA clear under K260149?

K260149 is the FDA 510(k) for Versus Catheter (VS110-9NB), submitted by Liquet Medical, Inc.. FDA's decision date was Feb 17, 2026, under product code QEY (Mechanical Thrombolysis Catheter).

Who makes the Versus Catheter (VS110-9NB)?

Liquet Medical, Inc., based in Glen Allen, VA, is the applicant of record for K260149.

How long did the K260149 review take?

FDA received the submission on Jan 20, 2026 and issued its decision on Feb 17, 2026, 28 days later.

← All decisions in February 2026